Abstract:Objective To investigate the association and related mechanisms between human circular RNA-0046366 (circRNA-0046366) and hepatocyte steatosis.Methods HepG2 cells were randomly divided into groups of normal control (n=3) and steatosismodel group (n=3), respectively.The normal control group was treated with DMEM, while the steatosis-model group was administrated with high-fat medium (OA∶PA=2∶1, 0.5 mmol/L) for 24 hours.Both oil red O staining and triglyceride (TG) concentration were employed to evaluate the hepatocyte steatosis.Hepatic level of malonaldehyde (MDA) reflected the lipid peroxidation, which occurred on the basis of hepatocyte steatosis.Real-time PCR exhibited the alternation of circRNA-0046366 expression during hepatic steatosis.Bioinformatic analysis demonstrated the target miRNA, and downstream mRNAs, of circRNA-0046366 by means of circBase searching and circRNA-miRNA complementation.Finally, the association among circRNA-0046366 level, miRNA, mRNAs, hepatocyte steatosis, and lipid peroxidation was assessed by Spearman correlation analysis.Results Compared with normal control group, steatosismodel group exhibited significant increase in lipid droplets, and hepatic contents TG [(24.4±2.4) μmol/g vs (263.7±17.5) μmol/g, P<0.05] and MDA [(0.6±0.1) μmol/g vs (1.8±0.2) μmol/g, P<0.05].The expression level of circRNA-0046366 underwent statistically decrease (P<0.05) during the hepatocyte steatosis.Both circRNA-0046366 and peroxisome proliferator-activated receptor α (PPARα) shared the sequence complementary to miR-34a, which may abolish the translational inhibition of miR-34a on PPARα by binding competition.In result, the circRNA-0046366 level correlated with PPARα expression (r=0.78, P<0.05), but negatively correlated with miR-34a level (r=-0.83, P<0.05), and concentrations of TG (r=-0.72, P<0.05) and MDA (r=-0.69, P<0.05) in the steatotic HepG2 cells.Conclusion circRNA-0046366 level negatively correlates with hepatic steatosis and lipid peroxidation.Abolishment of the PPARα inhibition by miR-34a may underlie its effect.

Circrna_0046367 Prevents Hepatoxicity of Lipid Peroxidation: an Inhibitory Role Against Hepatic Steatosis.

Circrna_0046366 Inhibits Hepatocellular Steatosis by Normalization of PPAR Signaling

Circular RNA circPSD3 alleviates hepatic fibrogenesis by regulating the miR-92b-3p/Smad7 axis

Circular RNA circFBXW4 suppresses hepatic fibrosis via targeting the miR-18b-3p/FBXW7 axis

The association and related mechanisms between human circRNA-0046366 and hepatocyte steatosis

Antagonizing circRNA_002581–miR-122–CPEB1 axis alleviates NASH through restoring PTEN–AMPK–mTOR pathway regulated autophagy

Circular RNA Circube2k Promotes Hepatic Fibrosis Via Sponging Mir‐149‐5p/tgf‐β2 Axis

Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis.

N6-methyladenosine-modified Circirf2, Identified by YTHDF2, Suppresses Liver Fibrosis Via Facilitating FOXO3 Nuclear Translocation.

Silencing of Hsa_circ_0008450 Represses Hepatocellular Carcinoma Progression Through Regulation of Microrna-214-3p/ezh2 Axis

Circular RNA Circ_0008934 Promotes Hepatocellular Carcinoma Growth and Metastasis Through Modulating Mir-1305/Tmtc3 Axis.

Effect of miR-34a in regulating steatosis by targeting PPARα expression in nonalcoholic fatty liver disease

A nanodrug system overexpressed circRNA_0001805 alleviates nonalcoholic fatty liver disease via miR-106a-5p/miR-320a and ABCA1/CPT1 axis

Proangiogenic Role of Circrna‐007371 in Liver Fibrosis

Knockdown of circ_0044226 promotes endoplasmic reticulum stress-mediated autophagy and apoptosis in hepatic stellate cells via miR-4677-3p/SEC61G axis

CircRNA-PI4KB Induces Hepatic Lipid Deposition in Non-Alcoholic Fatty Liver Disease by Transporting miRNA-122 to Extra-Hepatocytes

Circ_0003570 Suppresses the Progression of Hepatocellular Carcinoma Through Mir-182-5p/stard13 Regulatory Axis.

Circular RNA circ_0026218 Suppressed Atherosclerosis Progression via miR-338-3p/SIRT6 Axis

Circular RNA CREBBP Suppresses Hepatic Fibrosis Via Targeting the hsa-miR-1291/LEFTY2 Axis

Circ_0020887 Silencing Combats Hypoxic-Induced Cardiomyocyte Injury in an MiR-370-3p/CYP1B1-Dependent Manner

Inhibition of mmu_circ_0009303 improves metabolic dysfunction-associated steatotic liver disease by regulating lipid metabolism and oxidative stress